Clinical Trial Update: Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension Inadequately Controlled With AGLS [Phase 3]

View source ↗

Summary

Phase III trial evaluating AGSAVI for essential hypertension inadequately controlled with AGLS has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AGSAVI

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Essential Hypertension | Phase 3 | Status: COMPLETED